Screener
Vir Biotechnology, Inc. VIR Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| License and collaboration revenue | $238,935 | $(495) | $238,894 | $(565) |
| Grant revenue | 11 | 183 | 23 | 1,421 |
| Other revenue | — | 1,526 | — | 3,390 |
| Total revenues | 238,946 | 1,214 | 238,917 | 4,246 |
| Operating expenses: | ||||
| Cost of revenue | — | 11 | — | 11 |
| Research and development | 135,283 | 97,509 | 244,205 | 216,154 |
| Selling, general and administrative | 30,196 | 22,283 | 53,535 | 46,227 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s total revenue?
- Vir Biotechnology, Inc. (VIR) reported total revenue of $238.95M in Q2 2026.
- How has Vir Biotechnology, Inc.'s total revenue changed year-over-year?
- Vir Biotechnology, Inc.'s total revenue increased by 19582.5% year-over-year, from $1.21M to $238.95M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s total revenue has grown at a -50.0% compound annual growth rate (CAGR), from $1.1B to $68.56M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Vir Biotechnology, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude